Overview
- Description
The company develops innovative glyco-humanized antibody therapies for immunology, oncology, transplantation and infectious diseases.
- Website
- Country
- France
- Sector
- Health Biotechnology
XENOTHERA
Treat severe cases of infection at COV with XAV-19